Is there a role for testosterone or other hormones to recover nutritional and muscle mass parameters in a severely malnourished patient on dialysis (hemodialysis) with hypoalbuminemia (albumin 2.0) and receiving tube feeds (enteral nutrition)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Testosterone and Hormonal Therapy for Nutritional Recovery in Severely Malnourished Dialysis Patients

There is no established role for testosterone or other hormonal therapies in recovering nutritional and muscle mass parameters in severely malnourished dialysis patients with hypoalbuminemia receiving tube feeds. Instead, optimizing nutritional support through enteral nutrition and potentially intradialytic parenteral nutrition should be the primary approach.

Primary Nutritional Interventions for Severely Malnourished Dialysis Patients

  • Enteral nutrition (EN) should be the first-line nutritional intervention for malnourished dialysis patients who cannot meet at least 70% of their nutritional requirements through oral intake 1
  • For patients with severe malnutrition (albumin 2.0) on hemodialysis, specialized renal formulas with higher protein content and reduced electrolyte concentrations are recommended 2
  • Target protein intake should be 1.3 g/kg/day to address severe malnutrition while accounting for dialysis requirements 2
  • Target caloric intake should be 25-30 kcal/kg/day to promote nutritional recovery 2

Intradialytic Parenteral Nutrition (IDPN) Considerations

  • IDPN should be considered for malnourished dialysis patients who fail to respond to or cannot tolerate oral nutritional supplements (ONS) or enteral nutrition 1
  • IDPN has been shown to significantly improve albumin fractional synthetic rate during hemodialysis (16.2 ± 1.5%/d versus 12.8 ± 1.7%/d; p < 0.05) 3
  • IDPN can provide nutrients during hemodialysis sessions but is limited by being available only during dialysis (typically 4 hours, three times weekly) 1
  • Multiple studies have shown evidence for nutritional improvements with IDPN in patients with kidney failure on hemodialysis with protein-energy wasting 1

Addressing Dialysis Adequacy in Malnourished Patients

  • Consider increasing the dialysis dose in patients who are malnourished, as this may help improve nutritional status 1
  • For severely malnourished patients, increasing the minimum dialysis dose by approximately 25% (e.g., to an spKt/V of 1.5 for thrice-weekly hemodialysis) may be beneficial 1
  • Increasing dialysis frequency, rather than just increasing Kt/V in a thrice-weekly framework, may be a more effective strategy for improving nutritional parameters 1

Monitoring and Management Considerations

  • Electrolyte levels, including phosphate, potassium, and magnesium, should be closely monitored to prevent refeeding syndrome 2
  • Inflammation often contributes to hypoalbuminemia in dialysis patients, so addressing underlying infections or inflammatory conditions is crucial 4, 5
  • Serum albumin should be monitored regularly as a marker of nutritional status, with a target of 3.7 g/dL (BCP) according to KDOQI guidelines 6
  • Risk factors affecting nutritional status that should be addressed include poor dentition, infections, polypharmacy, and pain 6

Why Hormonal Therapy Is Not Recommended

  • Current clinical practice guidelines for nutrition in hospitalized patients with kidney disease do not recommend testosterone or other hormonal therapies for nutritional recovery 1
  • Guidelines emphasize optimizing nutritional support through enteral and parenteral routes rather than hormonal interventions 1
  • The pathogenesis of malnutrition in dialysis patients is complex, involving metabolic derangements, inflammation, and reduced nutrient intake, which are better addressed through nutritional interventions 1
  • Protein-energy wasting in dialysis patients can be effectively managed with proper nutritional support without the need for hormonal therapies 7

Practical Approach to Management

  1. Ensure adequate enteral nutrition through tube feeds with specialized renal formulas 2
  2. If enteral nutrition is insufficient, add IDPN during dialysis sessions 1
  3. Consider increasing dialysis dose or frequency to improve nutritional parameters 1
  4. Address and treat underlying inflammation or infections 4
  5. Monitor serum albumin and other nutritional parameters regularly 6
  6. Ensure adequate protein (1.3 g/kg/day) and caloric intake (25-30 kcal/kg/day) 2

By focusing on optimizing nutritional support and dialysis adequacy rather than hormonal therapies, clinicians can more effectively address malnutrition in severely malnourished dialysis patients.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Nutritional Management for Severe Gastroparesis and Malnutrition

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

[Nutritional status, comorbidity, and inflammation in hemodialysis].

Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, 2000

Research

[Hypoalbuminemia in dialysis. Is it a marker for malnutrition or inflammation?].

Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion, 2001

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.